Apollo Hospitals Enterprise Limited · NSE:APOLLOHOSP

Apollo Hospitals Enterprise — Q4 FY24 Earnings Presentation

30 slides from Apollo Hospitals Enterprise's earnings presentation, May 30, 2024

  1. Slide 1: Regulation 30 disclosure cover letter to stock exchanges

    APOLLO HOSPITALS ENTERPRISE LIMITED .~ /1110 CIN : L8511OTN1979PLC008035 ~OSPITALS 30th May 2024 The Secretary, The Secretary, Bombay Stock Exchange Ltd (BSE) National Stock Exchange, Phiroze Jheejheebhoy Towers, Exchange Plaza, 5th Floor Dalal Street, Plot No.C/1, 'G' Block Mumbai - 400 001. Bandra

  2. Slide 2: Earnings Update Q4 FY24

    APOLLO HOSPITALS ENTERPRISE LIMITED Earnings Update Q4 FY24

  3. Slide 3: Operational & Financial Snapshot, Consolidated Financials, Healthcare Services

    01 Operational & 02 Consolidated 03 Healthcare Services Financial Snapshot Financials 04 05 Digital Health 06 Annexure Diagnostics & Retail Health (AHLL) & Pharmacy Distribution (Apollo HealthCo) 2

  4. Slide 4: Operational & Financial Snapshot

    Operational & Financial Snapshot 3

  5. Slide 5: Q4FY24 Operational Snapshot

    Q4FY24 Operational Snapshot Healthcare Services 45 Owned 9,500 142,122 (Hospitals) + 65% ` 59,523 / day Owned & In-patients 6 Managed Managed Occupancy ARPOB1 Hospitals Beds FY24 : 65% FY24: ` 57,488 FY24: 569,988 Diagnostics & 22 Retail Health Ambulatory 634 2,366 283 136 167 care & Birthing Beds D

  6. Slide 6: Clinical Updates/New Initiatives

    • Apollo Hospitals revolutionizes prostate cancer screening for Indian men with groundbreaking study titled “Determining age-specific prostate-specific antigen for healthy Indian men”. The study involved nearly 100,000 healthy men across diverse age groups and regions in India, establishing new refe

  7. Slide 7: Q4 FY24 Financial Snapshot

    Q4 FY24 Financial Snapshot Growth Growth EBITDA Growth (in ₹ Mio) Revenue YoY(%) EBITDA(Post Ind AS) YoY(%) Margin (%) PAT YoY(%) Healthcare Services 25,626 17% 5,931 11% 23.1% 2,803 9% Offline PD^ 17,880 12% 11% 7.5% 1,336 Health Co Online PD^ & 2,387 20% (1,219) NA 24|7 Total Health 13%* (177) 20,

  8. Slide 8: FY24 Financial Snapshot

    FY24 Financial Snapshot Growth Growth EBITDA Growth (in ₹ Mio) Revenue YoY(%) EBITDA(Post Ind AS) YoY(%) Margin (%) PAT YoY(%) 11,450 Healthcare Services 98,670 14% 23,559 10% 23.9% 131% Offline PD^ 69,268 14% 5,230 10% 7.6% Health Co Online PD^ & 38% 9,001 (6,047) NA 24|7 Total Health 17%* (1,957)

  9. Slide 9: Consolidated Financials

    Consolidated Financials 8

  10. Slide 10: Consolidated Financials Q4 FY24

    Consolidated Financials Q4 FY24 Digital Health ` Mio Total Revenues Healthcare Services 25,626 Diagnostics & Retail Health 3,547 & Pharmacy Distribution 20,267 Consol 49,439 - Overall Consolidated Revenue grew by 15% to ` 49,439 mio. EBITDA (Pre 24|7 Cost) 5,931 357 1,625 7,913 • HCS Revenue grew by

  11. Slide 11: Consolidated Financials FY24

    Consolidated Financials FY24 Digital Health Healthcare Diagnostics & ` Mio & Pharmacy Consol Services Retail Health Distribution Health HCS AHLL Total Revenues 98,670 13,653 78,269 190,592 Co EBITDA (Pre 24|7 Cost) 23,559 1,166 6,260 30,984 margin (%) 23.9% 8.5% 8.0% 16.3% 24|7 Operating Cost -6,186

  12. Slide 12: Healthcare Services

    Healthcare Services Hospitals 11

  13. Slide 13: Consolidated Healthcare Services Performance

    Consolidated Healthcare Services Performance ` Mio No of Hospitals Operating beds Q4 FY24 45 7,945 Q4 FY23 43 7,860 YoY FY24 45 7,945 FY23 43 7,860 YoY - HCS Revenue grew by 14% in FY24 (Volumes grew by 5%) Occupancy Revenue 65% 25,626 64% 21,946 17% 65% 98,670 64% 86,768 14% - Self pay and Insuranc

  14. Slide 14: Region wise Operational Parameters Q4FY24

    Region wise Operational Parameters Q4FY24 Tamilnadu Region AP, Telengana Region Karnataka Region Total (7) (Chennai & others) (1) (Hyderabad & others) (2) (Bangalore & others) (3) Particulars Q4 FY 23 Q4 FY 24 yoy (%) Q4 FY 23 Q4 FY 24 yoy (%) Q4 FY 23 Q4 FY 24 yoy (%) Q4 FY 23 Q4 FY 24 yoy (%) No.

  15. Slide 15: Region wise Operational Parameters FY24

    Region wise Operational Parameters FY24 Tamilnadu Region AP, Telengana Region Karnataka Region Total (7) (Chennai & others) (1) (Hyderabad & others) (2) (Bangalore & others) (3) Particulars FY 23 FY 24 yoy (%) FY 23 FY 24 yoy (%) FY 23 FY 24 yoy (%) FY 23 FY 24 yoy (%) No. of Operating beds 7,860 7,

  16. Slide 16: Strong ROCE across Metros and Non Metros

    Strong ROCE across Metros and Non Metros Metros: Chennai, Hyderabad, Bangalore, Mumbai, Kolkata and Delhi Non Metros (includes Tier1 & Tier2 cities) Metros Non Metros Ahmedabad, Bhubaneshwar, Lucknow, Indore Guwahati, Madurai, Trichy, Nellore,Vizag, Mysore, Nashik, Bilaspur, Karimnagar, Karur, Karai

  17. Slide 17: Healthcare Services: Expansion Plan

    Healthcare Services : Expansion Plan Total Census Project Cost Project Nature Remarks Beds Beds (in Crs) Expected commisioning : FY25 Gachibowli, Hyderabad Greenfield - Asset Light 375 300 ₹ 370 Q4 FY25 Bangalore Brownfield 150 110 ₹ 150 Q4 FY25 Sonarpur Kolkata Hospital Asset Acquisition 220 180 ₹

  18. Slide 18: Diagnostics & Retail Health

    Diagnostics & Retail Health Apollo Health & Lifestyle Ltd 17

  19. Slide 19: Executive Summary

    Executive Summary ➢ Core revenues of Primary Care grew by 15% YOY in FY’24 ➢ Expanding Primary Care Network for communities with increased focus on Preventive Health & NCDs Primary Care ➢ Preventive Health-check grew by ~30%; driven by new initiatives viz. Apollo ProHealth ➢ Partnership with Private

  20. Slide 20: Financial Performance Q4FY24

    Financial Performance Q4FY24 Q4 FY24 Clinics Diagnostics Sugar Dental Dialysis Cradles (IP) IVF Spectra (IP) Network 283 2,366 69 167 136 11 17 11 Footfalls/Day* 2,624 15,143 487 223 2,108 56 45 76 Gross ARPP (Rs.)* 2,162 731 3,021 6,502 1,633 106,847 41,202 97,016 Specialty AHLL ` Mio Q4 FY24 Diagn

  21. Slide 21: Financial Performance FY24

    Financial Performance FY24 FY24 Clinics Diagnostics Sugar Dental Dialysis Cradles (IP) IVF Spectra (IP) Network 283 2,366 69 167 136 11 17 11 Footfalls/Day* 2,551 14,986 492 225 1,974 54 43 74 Gross ARPP (Rs.)* 2,073 740 3,028 6,401 1,623 105,028 40,216 98,997 ` Mio Diagnostics Primary Care Specialt

  22. Slide 22: Diagnostics: Key Parameters

    Diagnostics : Key Parameters Gross Revenue (INR Mn)1 EBITDA (INR Mn)2 Operational footprint 1,239 1,122 1,169 (as of March 31, 2024) 1,040 1,031 1,075 3 940 4 5 16 816 118 15 24 12% ~330+ 99 14% 14% Cities 1,236 1,164 10% 1,016 1,059 1,118 5% 7% presence 922 916 148 168 717 5% 5% 149 75 112 39 51 50

  23. Slide 23: Digital Health & Pharmacy Distribution

    Digital Health & Pharmacy Distribution Apollo Health Co 22

  24. Slide 24: India's Largest Omni-Channel Healthcare Platform

    India’s Largest Omni-Channel Healthcare Platform Apollo 247 –Digital Platform Apollo Pharmacy Platform Q4 24 FY 24 As at March 31, 2024 Added 248 529 ~33 Mn+ 6.9 Lakh* ~7,335 Closed 8 40 Registrations Daily Active Users Doctors Net 240 489 (I) Chandigarh: 4 Doctor Consultation Daily Consultation Him

  25. Slide 25: Apollo HealthCo Financials Q4 FY24

    Apollo HealthCo Financials Q4 FY24 Offline Pharmacy Online Pharmacy Healthco ( Q4’FY 24 vs Q4’FY 23) : ` Mio Distribution & Total Health Co Distribution Apollo 247 o 13% growth in revenue in Q4’ FY24 vs Q4’ FY23 Total Revenues 17,880 2,387 20,267 EBITDA (Post Ind AS 116)* 1,336 289 1,625 o EBITDA po

  26. Slide 26: Apollo HealthCo Financials FY24

    Apollo HealthCo Financials FY24 Offline Online Pharmacy ` Mio Pharmacy Distribution & Total Health Co Healthco : Distribution Apollo 247 o Platform GMV : Rs 26,870 Mn in FY24, growth of 73% over FY23 Total Revenues 69,268 9,001 78,269 EBITDA (Post Ind AS 116)* 5,230 1,029 6,260 margin (%) 7.6% 11.4%

  27. Slide 27: Annexure

    Annexure 26

  28. Slide 28: Basis of Consolidation

    Basis of Consolidation AHEL AHEL Standalone Hospitals (100% Ownership) Location Subsidiaries Location Description Ownership Chennai Main Chennai Material Subs ACI - Chennai Chennai Apollo Health Co limited India Digital Omni-Channel Healthcare services Platform 100.00% Tondiarpet - Chennai Chennai A

  29. Slide 29: IND AS 116: Impact on P&L and Balance Sheet FY24

    ` Mio IND AS - 116 : Impact on P&L and Balance Sheet –FY24 AHEL Standalone (post IND AS 116) AHEL Consolidated (post IND AS 116) Balance sheet Profit & Loss Balance sheet Profit & Loss Right of use 12,612 Revenue Right of use 19,743 Revenue Asset Asset Other 1,003 as of Other as of 2,236 expenses 31

  30. Slide 30: Thank you!

    Thank you ! 29

Apollo Hospitals Enterprise — Q4 FY24 Earnings Presentation on 6ix